In the tumor microenvironment, it has been identified that IL2 signals promote the production of cytokines including FLT3L, CSF-2, and TNF from T cells and NK cells, and induces DCs expansion, activation and antigen processing, which resulted in favorable anticancer responses in mice and patients with melanoma [18]. This evidence concerns the gene IL2 and neoplasm.